K. C. Pharmaceuticals, Inc. is voluntarily recalling over 3 million eye drops that were distributed nationwide, according to a notice from the US Food and Drug Administration (FDA). The recall was initiated on March 3, 2026, and classified on March 31.
The reason for the recall is “lack of assurance of sterility.” The FDA noted that the eye drops were distributed by companies in the United States such as Walgreens, CVS, and Kroger, among others. The FDA classified the recall as a Class II, which it defines as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
According to the FDA, the recalled products include the following:
-
Sterile Eye Drops AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl. oz. (15 mL) bottles
-
Eye Drops Advanced Relief, (dextran 70 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl 0.05%), 0.5 FL oz (15 mL) bottles, Sterile
-
Dry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL oz (15 mL) bottles
-
Ultra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), Sterile, 0.5 FL oz (15mL) bottles
-
Sterile Eye Drops Original Formula (tetrahydrozoline HCl 0.05%), 0.5 FL oz (15mL) bottles
-
Sterile Eye Drops Redness Lubricant (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL) bottles
-
Sterile Eye Drops Soothing Tears (polyethylene glycol 400 0.4% and propylene glycol 0.3%), 0.5 oz 0.5 fl oz (15 mL) bottles
-
Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL oz (15 mL) bottles







